F. Silvestris et al., CROSS-LINKING OF FAS BY ANTIBODIES TO A PECULIAR DOMAIN OF GP120 V3 LOOP CAN ENHANCE T-CELL APOPTOSIS IN HIV-1-INFECTED PATIENTS, The Journal of experimental medicine, 184(6), 1996, pp. 2287-2300
Previous studies have demonstrated that T cell-reactive antibodies in
HIV-1 infection contribute to lymphocyte depletion by cytotoxicity tha
t involves differential membrane targets, such as the 43.5-kD receptor
on CEM cells. Here, we show that these antibodies bind Fas as result
of a molecular mimicry of the gp120. Both now cytometry and immunoblot
ting using the human Fas-transfected mouse WC8 lymphoma revealed posit
ive binding of immunoglobulin G from several patients to a 43.8-kD mem
brane receptor that also reacts with the CH11 anti-Fas monoclonal anti
body. Specificity to Fas was further confirmed to chimeric recombinant
human Fas-Fc by ELISA, whereas overlapping peptide mapping of a Fas d
omain (VEINCTR-N) shared by gp120 V3 loop demonstrated a predominant a
ffinity to the full-length 10-mer peptide. Four anti-Fas affinity prep
arations greatly increased the subdiploid DNA peak of CEM cells simila
r to agonist ligands of Fas. In addition, anti-Fas immunoglobulin G st
rongly inhibited the [H-3]thymidine uptake of CEM cells in proliferati
ve assays, inducing a suppression as high as provoked by both CH11 mAb
and recombinant human Fas ligand. Since anti-Fas were reactive to gp1
20, it is conceivable that antibodies binding that domain within the V
3 region are effective cross-linkers of Fas and increase apoptosis in
peripheral T cells. These results suggest gest that autologous stimula
tion of the Fas pathway, rather than of lymphocytotoxic antibodies, ma
y aggravate lymphopenia in a number of HIV-1(+) subjects.